- Home
- HMN vs OCUL Comparison
HMN vs OCUL Comparison
Compare HMN & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HMN | OCUL |
|---|---|---|
| Founded | 1945 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HMN | OCUL |
|---|---|---|
| Price | $48.54 | $9.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $47.33 | $23.56 |
| AVG Volume (30 Days) | 240.7K | ★ 2.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.05% | N/A |
| EPS Growth | ★ 57.26 | N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | ★ $1,701,400,000.00 | $1,990,000.00 |
| Revenue This Year | $6.91 | $7.93 |
| Revenue Next Year | $3.41 | $96.07 |
| P/E Ratio | $48.71 | ★ N/A |
| Revenue Growth | ★ 6.66 | 3.48 |
| 52 Week Low | $40.04 | $6.23 |
| 52 Week High | $49.60 | $16.44 |
Technical Indicators
Market Signals| Indicator | HMN | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 63.34 | 54.33 |
| Support Level | $43.50 | $8.10 |
| Resistance Level | N/A | $9.27 |
| Average True Range (ATR) | 1.07 | 0.46 |
| MACD | 0.21 | 0.08 |
| Stochastic Oscillator | 79.42 | 79.57 |
Price Performance
Historical ComparisonAbout HMN Horace Mann Educators Corporation
Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.